AstraZeneca’s (AZN.L) antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, was also shown to save lives and prevent severe disease when given as treatment…
(Reuters) – Merck & Co Inc (MRK.N) said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to…
WELLINGTON (Reuters) – New Zealand on Monday abandoned its long-standing strategy of eliminating coronavirus amid a persistent Delta outbreak, and will instead look to live with the virus and control…
PARIS (Reuters) -Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna (NASDAQ:MRNA) in using the technology to fight the pandemic, the company…